Supplementation of a novel microbial biopolymer, PGB1, from new Enterobacter sp. BL-2 delays the deterioration of type 2 diabetic mice

Journal of Microbiology and Biotechnology

Volumn 17, Issue 12, 2007, Pages 1983-1990

  Yeo, Jiyoung ^a   Lee, Yong Hyun ^a   Jeon, Seon Min ^a   Jung, Un Ju ^a   Lee, Mi Kyung ^b   Jung, Young Mi ^a   Choi, Myung Sook ^a  

^a Kyungpook National University   (South Korea)

^b Sunchon National University   (South Korea)

Author keywords

Blood glucose lowering; C57BL KsJ db db mice; Enterobacter sp. BL 2; Microbial biopolymer; PGB1; Type 2 diabetes

Indexed keywords

BIOLOGICAL MARKER; BIOPOLYMER; GLUCOKINASE; GLUCOSE; GLYCOGEN; INSULIN; POLYGLUCOSAMINE BIOPOLYMER; ROSIGLITAZONE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; DRUG ACTIVITY; DRUG MEGADOSE; ENTEROBACTER; ENZYME ACTIVITY; FOOD INTAKE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; IMMUNOHISTOCHEMISTRY; INSULIN RELEASE; LOW DRUG DOSE; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET;

ANIMALS; BIOPOLYMERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; ENTEROBACTER; GLUCOSAMINE; GLUCOSE TOLERANCE TEST; HYPOGLYCEMIC AGENTS; IMMUNOHISTOCHEMISTRY; INSULIN; LIVER GLYCOGEN; MALE; MICE; MICE, INBRED C57BL; PANCREAS; RANDOM ALLOCATION; THIAZOLIDINEDIONES;

ANIMALIA; ENTEROBACTER SP. BL-2; MUS;

EID: 38149092386     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: None     Document Type: Article

References (56)

1. Alegre, M., C. J. Ciudad, C. Fillat, and J. J. Gulnovant. 1988. Determination of glucose-6-phosphatase activity using the glucose dehydrogenase-coupled reaction. Anal. Biochem. 173: 185-189.
2. American Diabetes Association. 1998. Consensus development conference on insulin resistance. Diabetes Care 21: 310-312.
3. American Institute of Nutrition. 1977. Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 107: 1340-1348.
4. American Institute of Nutrition. 1980. Report of ad hoc committee on standards for nutritional studies. J Nutr. 110: 1717-1726.
5. Avandia [package insert]. 1999. SmithKline Beecham Pharmaceuticals, Philadelphia, Pa.
6. Bentle, L. A. and H. A. Lardy. 1976. Interaction of anions and divalent metal ions with phosphopyruvate carboxykinase. J. Biol. Chem. 251: 2916-2921.
7. Bradford, M. M. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72: 248-254.
8. Chang, M. S., M. S. Oh, D. R. Kim, K. J. Jung, S. M. Park, S. B. Choi, B. S. Ko, and S. K. Park. 2006. Effects of Okchun-San, a herbal formulation, on blood glucose levels and body weight in a model of type 2 diabetes. J. Ethnopharmacol. 103: 491-495.
9. Davidsion, A. L. and W. J. Arion. 1987. Factors underlying significant underestimations of glucokinase activity in crude liver extracts: Physiological implications of higher cellular activity. Arch. Biochem. Biophys. 253: 156-167.
10. Davis, G. F., R. L. Khandelwal, L. Wu, B. H. Juurlink, and W. J. Roesler. 2001. Inhibition of phosphoenolpyruvate carboxykinase (PEPCK) gene expression by troglitazone: A peroxisome proliferators-activated receptor-gamma (PPAR gamma)-independent, antioxidant-related mechanism. Biochem. Pharmacol. 62: 1071-1079.
11. Dermlim, W., P. Prasertsan, and H. Doelle. 1999. Screening and characterization of bioflocculant produced by isolated Klebsiella sp. Appl. Microbiol. Biotechol. 52: 698-703.
12. Defronzo, R. A. 1988. The triumvirate; beta-cell, muscle, liver. A collusion responsible for type 2 diabetes. Diabetes 37: 667-687.
13. Deng, S. B., R. B. Bai, X. M. Hu, and Q. Luo. 2003. Characteristics of a bioflocculant produced by Bacillus mucilaginosus and its use in starch wastewater treatment. Appl. Microbiol. Biotechol. 60: 588-593.
14. Dora, R. F. 1996. Diabetes mellitus, pp. 613-641. In L. A. Kaplan and J. P. Amadeo (eds.), Clinical Chemistry. Mosby-Year Book, St. Louis, MO, U.S.A.
15. Fujita, M., M. Ike, J. H. Jang, S. M. Kim, and T. Hirao. 2001. Bioflocculation production from lower-molecular fatty acids as a novel strategy for utilization of sludge digestion liquor. Water Sci. Technol. 144: 237-243.
16. Guignot, L. and G. Mithieux. 1999. Mechanisms by which insulin, associated or not with glucose, many inhibit hepatic glucose production in the rat. Am. J. Physiol. 277: E984-E989.
17. He, P., S. S. Davis, and L. Illum. 1998. In vitro evaluation of mucoadhesive properties of chitosan microspheres. Int. J. Pharm. 166: 75-88.
18. Hornbrook, K. R. 1970. Synthesis of liver glycogen in starved alloxan diabetic rat. Diabetes 19: 916-923.
19. Hulcher, F. H. and W. H. Oleson. 1973. Simplified spectrophotometric assay for microsomal 3-hydroxy-3-methylglutaryl CoA reductase by measurement of coenzyme A. J. Lipid Res. 14: 625-631.
20. Hummel, K. P., M. W. Dickie, and D. L. Coleman. 1966. Diabetes, new mutation in the mouse. Science 153: 1127-1128.
21. Jang, J. H., M. Ike, S. M. Kim, and M. Fujita. 2001. Production of a novel bioflocculant by fed-batch culture of Citrobacter sp. Biotechnol. Lett. 23: 593-597.
22. Jeon, C. 2005. Mercury ion removal using a packed-bed column with granular aminated chitosan. J. Microbiol. Biotechnol. 15: 497-501.
23. Jovanovic, L. and C. M. Peterson. 1981. The clinical utility of glycosylated hemoglobin. Am. J. Med. 70: 331-338.
24. King, H., R. Aubert, and W. Herman. 1998. Global burden of diabetes, 1995-2025. Prevalence, numerical estimates and projections. Diabetes Care 21: 1414-1431.
25. y mice. Biol. Pharm. Bull. 25: 188-192.
26. Krishnamurti, U. and M. W. Steffes. 2001. Glycohemoglobin: A primary predictor of the development or reversal of complications of diabetes mellitus. Clin. Chem. 47: 1157-1165.
27. Kurane, R., K. Toeda, and T. Suzuku. 1986. Culture conditions for production of microbial flocculant by Rhodococcus erythropolis. Agric. Biol. Chem. 50: 2309-2313.
28. Kwon, Y. D., S. Y. Lee, and P. Kim. 2006. Influence of gluconeogenic phosphoenolpyruvate carboxykinase (PCK) expression on succinic acid fermentation in Escherichia coli under high bicarbonate condition. J. Microbiol. Biotechnol. 16: 1448-1452.
29. Kyotani, S., Y. Nishioka, T. Okamura, T. Tanaka, M. Miyazaki, and S. Tanada. 1992. A study of embolizing materials for chemo-embolization therapy of hepatocellular carcinoma: Antitumor effect of cis-diamminedichloroplatinum (II) albumin microspheres, containing chitin and treated with chitosan on rabbits with VX2 hepatic tumors. Pharm. Bull. 40: 2814-2816.
30. Lehmann, J. M., L. B. Moore, T. A. Smith-Oliver, et al. 1995. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor gamma (PPAR gamma). J. Biol. Chem. 270: 12953-12956.
31. Lehoux, J. G. and F. Grondin. 1993. Some effects of chitosan on liver function in the rat. Endocrinology 132: 1078-1084.
32. Lehr, C., J. A. Bouwatra, E. H. Schacht, and H. E. Junginer. 1992. In vitro evaluation of mucoadhesive properties of chitosan and some other natural polymers. Int. J. Pharm. 76: 43-49.
33. Lynedjian, P. B., A. Gjinovci, and A. E. Renold. 1988. Stimulation by insulin of glucokinase gene transcription in liver of diabetic rats. J. Biol. Chem. 263: 740-744.
34. Migliorini, R. H. 1971. Early changes in the levels of liver glycolytic enzymes after total pancreatectomy in the rat. Biochim. Biophys. Acta 244: 125-128
35. Mima, S., M. Miya, R. Iwamoto, and S. Yoshikawa. 1983. Highly deacetylated chitosan and its properties. J. Appl. Polym. Sci. 28: 1909-1917.
36. Miura, T., M. Usami, Y. Tsuura, H. Ishida, and Y. Seino. 1995. Hypoglycemic and hypolipidemic effect of chitosan in normal and neonatal streptozotocin-induced diabetic mice. Biol. Pharm. Bull. 18: 1623-1625.
37. Murata, J., I. Saiki, T. Makabe, Y. Tsuta, S. Yokura, and I. Azuma. 1999. Inhibition of tumor-induced angiogenesis by sulfated chitin derivatives. Cancer Res. 51: 22-26.
38. Oh, H. M., S. J. Lee, M. H. Park, H. S. Kim, H. C. Kim, J. H. Yoon, G. S. Kwon, and B. D. Yoon. 2001. Harvesting of Chlorella vulgaris using a bioflocculant from Paenibacillus sp. AM49. Biotechnol. Lett. 23: 1229-1234.
39. Reaven, G. M. 1997. Banting lecture. Role of insulin resistance in human disease. Nutrition 13: 64-66.
40. Saltiel, A. R. and J. M. Olefsky. 1996. Thiazolidinediones in the treatment of insulin resistance and type II diabetes. Diabetes 45: 1661-1669.
41. Seifter, S., S. Dayton, B. Novic, and E. Muntwyler. 1950. The estimation of glycogen with the anthrone reagent. Arch. Biochem. Biophys. 50: 191-200.
42. Son, M, K., H. D. Shin, T. L. Huh, J. H. Jang, and Y. H. Lee. 2005. Novel cationic microbial polyglucosarnine biopolymer from new Enterobacter sp. BL-2 and its bioflocculation efficacy. J. Microbiol. Biotechnol. 15: 626-632.
43. Spiegelman, B. M. 1998. PPAR-gamma: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47: 507-514.
44. Park, S. A., M. S. Choi, M. J. Kim, U. J. Jung, H. J. Kim, and M. K. Lee. 2006. Hypoglycemic and hypolipidemic action of Du-zhong ( Eucommia ulmoides Oliver) leaves water extract in C57BL/KsJ- db/db mice. J. Ethnopharmacol. 107: 412-417.
45. Park, S. A., M. S. Choi, S. Y. Cho, J. S. Seo, and M. K. Lee. 2006. Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci. 79: 1207-1213.
46. Toeda, K. and R. Kurane. 1991. Microbial flocculant from Alcalgenes cupidus KT 201. Agric. Biol. Chem. 55: 2663-2664.
47. Valera, A. and F. Bosch. 1994. Glucokinase expression in rat hepatoma cells induces glucose uptake and is rate limiting in glucose utilization. Eur. J. Biochem. 222: 533-539.
48. Watanebe, M., Y. Suzuki, K. Sasaki, Y. Nakashimada, and N. Nishio. 1999. Flocculating property of extracellular polymeric substance derived from a marine photosynthetic bacterium, Rhodovulum sp. J. Biosci. Bioeng. 87: 625-629.
49. Whitmore, F. A. 1992. A hemagglutinating substance in chitin. Biotechniques 12: 202-207.
50. Whitton, P. D. and D. A. Hems. 1975. Glycogen synthesis in the perfused liver of streptozotocin-diabetic rats. Biochem. J. 150: 153-165.
51. Wu, Z. H., Q. N. Ping, W. E. I, Yi, and J. M. Lai. 2004. Hypoglycemic efficacy of chitosan-coated insulin liposomes after oral administration in mice. Acta Pharmacol. Sin. 25: 966-972.
52. Yokoi, H., T. Aratake, J. Hirose, S. Hayashi, and Y. Takasaki. 2001. Simultaneous production of hydrogen and bioflocculant by Enterbacter sp. BY-29. World J. Microbiol. Biotechnol. 17: 609-631.
53. Yoon, S. H., K. J. Song, S. J. Go, and J. C. Ryu. 1998. Production of biopolymer flocculant by Bacillus subtillis TB-11. J. Microbiol. Biotechnol. 8: 606-612.
54. Young, P. W., D. R. Buckle, B. C. Cantello, and S. A. Smith. 1998. Idendification of high affinity binding sites for the insulin sensitizer rosiglitazone (BRL-49653) in rodent and human adipocytes using a radioiodinated ligand for peroxisomal proliferator activated receptor gamma. J. Pharmacol. Exp. Ther. 284: 751-759.
55. Yu, K. W., K. S. Shin, Y. M. Choi, and H. J. Suh. 2004. Macrophage stimulating activity of exo-biopolymer from submerged culture of Lentinus edodes with rice bran. J. Microbiol. Biotechnol. 14: 658-664.
56. Zacour, A. C., M. E. Silva, P. R. Cecon, E. A. Bambirra, and E. C. Vieira. 1992. Effect of dietary chitin on cholesterol absorption and metabolism in rats. J. Nutr. Sci. Vitaminol. 38: 609-613.